Cerruto Maria Angela, D'Elia Carolina, Siracusano Salvatore, Saleh Omar, Gacci Mauro, Cacciamani Giovanni, De Marco Vincenzo, Porcaro Antonio Benito, Balzarro Matteo, Niero Mauro, Lonardi Cristina, Iafrate Massimo, Bassi Pierfrancesco, Imbimbo Ciro, Racioppi Marco, Talamini Renato, Ciciliato Stefano, Serni Sergio, Carini Marco, Verze Paolo, Artibani Walter
Urology Clinic, Department of Surgery Dentistry Paediatrics, and Gynaecology, University of Verona, Verona, Italy.
Department of Urology, Bolzano General Hospital, Bolzano.
Urology. 2017 Oct;108:82-89. doi: 10.1016/j.urology.2017.06.022. Epub 2017 Jun 23.
To examine the different and health-related quality of life (HR-QoL) outcomes between ileal conduit (IC) and ileal orthotopic neobladder (IONB) in patients who underwent radical cystectomy (RC), by using validated self-reported cancer-specific instruments.
This retrospective, cross-sectional, multicenter cohort study included 148 and 171 patients with either IC or IONB. HR-QoL was evaluated with Quality of Life Core Questionnaire and bladder module (BLM)-30 European Organisation for Research and Treatment of Cancer questionnaires. Baseline HR-QoL scores were dichotomized at the median to give "good" or "poor" score profiles. A matched-pair analysis compared HR-QoL aspects between 79 IC patients and 79 IONB patients.
At univariate analysis IONB resulted favorable for physical functioning, emotional functioning, cognitive functioning (CF), fatigue, dyspnea, appetite loss, constipation (CO), and abdominal bloating flatulence (AB). At multivariate analyses, IONB showed better scores for emotional functioning (85 vs 79, P = .023), CF (93 vs 85, P <.001), CO (16 vs 31, P <.001), and AB (12 vs 25, P <.001). A significant worsening of sexual and urinary function was observed for IONB patients in the long-term. At matched-pair analysis, global health status was similar (65 vs 62, P = .385). Significantly better scores were observed in the IONB group for the following items: CF (P = .007), fatigue (P = .003), pain (P = .019), dyspnea (P = .016), CO (P = .001), and AB (P = .00).
IONB and IC after RC were similar in terms of global health status. IONB provides better results in some aspects of HR-QoL related to bowel function, but a worsening of urinary and sexual functions. Further randomized controlled trials are needed to confirm these data.
通过使用经过验证的自我报告癌症专用工具,研究接受根治性膀胱切除术(RC)的患者中回肠膀胱术(IC)和原位回肠新膀胱术(IONB)之间不同的与健康相关的生活质量(HR-QoL)结果。
这项回顾性、横断面、多中心队列研究纳入了148例接受IC手术和171例接受IONB手术的患者。使用生活质量核心问卷和膀胱模块(BLM)-30欧洲癌症研究与治疗组织问卷对HR-QoL进行评估。将基线HR-QoL分数按中位数进行二分,以得出“良好”或“不佳”的分数概况。配对分析比较了79例IC患者和79例IONB患者之间的HR-QoL方面。
在单因素分析中,IONB在身体功能、情绪功能、认知功能(CF)、疲劳、呼吸困难、食欲减退、便秘(CO)和腹胀气(AB)方面表现较好。在多因素分析中,IONB在情绪功能(85对79,P = 0.023)、CF(93对85,P < 0.001)、CO(16对31,P < 0.001)和AB(12对25,P < 0.001)方面得分更高。长期来看,IONB患者的性功能和泌尿功能明显恶化。在配对分析中,总体健康状况相似(65对62,P = 0.385)。IONB组在以下项目上的得分明显更高:CF(P = 0.007)、疲劳(P = 0.003)、疼痛(P = 0.019)、呼吸困难(P = 0.016)、CO(P = 0.001)和AB(P = 0.00)。
RC术后IONB和IC在总体健康状况方面相似。IONB在与肠道功能相关的HR-QoL某些方面提供了更好的结果,但泌尿和性功能有所恶化。需要进一步的随机对照试验来证实这些数据。